Skip to main content
. 2023 Sep 21;17:1603. doi: 10.3332/ecancer.2023.1603

Table 3. Region and gender-wise ASIR of leading HNC sites (2012–2019).

ICD-10 Site Central East North Northeast South West India
Male
All All site (H&N) 28.3 18.3 28.5 31.7 23.9 24.4 25.9
(27.4–29.2) (17.5–19.1) (27.9–29.1) (31.1–32.3) (23.5–24.3) (24.0–24.8) (25.7–26.1)
1 in 31 1 in 47 1 in 30 1 in 26 1 in 35 1 in 36 1 in 33
C03-C06 Mouth 12.8 5.9 9.1 5.6 7.3 10.8 8.7
(12.2–13.4) (5.5–6.3) (8.8–9.4) (5.3–5.9) (7.1–7.5) (10.6–11.0) (8.6–8.8)
1 in 71 1 in 147 1 in 97 1 in 145 1 in 121 1 in 83 1 in 101
C01-C02 Tongue 6.4 4.4 7.2 5.0 6.1 5.8 5.9
(6.0–6.8) (4.0–4.8) (6.9–7.5) (4.8–5.2) (5.9–6.3) (5.6–6.0) (5.8–6.0)
1 in 144 1 in 214 1 in 120 1 in 166 1 in 143 1 in 156 1 in 149
C32 Larynx 4.3 4.3 5.7 5.2 4.3 3.2 4.3
(3.9–4.7) (3.9–4.7) (5.4–6.0) (4.9–5.5) (4.1–4.5) (3.1–3.3) (4.2–4.4)
1 in 178 1 in 192 1 in 142 1 in 156 1 in 180 1 in 253 1 in 185
C12-C13 Hypopharynx 2.0 1.7 2.0 8.0 2.6 2.0 3.1
(1.8–2.2) (1.5–1.9) (1.8–2.2) (7.7–8.3) (2.5–2.7) (1.9–2.1) (3.0–3.2)
1 in 399 1 in 480 1 in 398 1 in 101 1 in 310 1 in 404 1 in 267
C09 Tonsil 1.1 0.6 1.7 2.4 0.8 0.7 1.2
(0.9–1.3) (0.5–0.7) (1.6–1.8) (2.2–2.6) (0.7–0.9) (0.6–0.8) (1.15–1.25)
1 in 727 1 in 1,341 1 in 493 1 in 347 1 in 1,093 1 in 1,205 1 in 721
C10 Other oropharynx 0.5 0.4 1.4 1.4 1.5 0.5 1.0
(0.4–0.6) (0.3–0.5) (1.3–1.5) (1.3–1.5) (1.4–1.6) (0.4–0.6) (0.96–1.04)
1 in 1,687 1 in 2,267 1 in 564 1 in 583 1 in 517 1 in 1,564 1 in 775
C11 Nasopharynx 0.3 0.4 0.5 2.3 0.5 0.3 0.7
(0.2–0.4) (0.3–0.5) (0.4–0.6) (2.1–2.5) (0.4–0.6) (0.26–0.34) (0.66–0.74)
1 in 2,786 1 in 1,963 1 in 1,940 1 in 375 1 in 1,907 1 in 3,099 1 in 1,298
C14 Pharynx unspecified 0.3 0.5 0.4 1.4 0.4 0.5 0.6
(0.2–0.4) (0.4–0.6) (0.3–0.5) (1.3–1.5) (0.3–0.5) (0.4–0.6) (0.57–0.63)
1 in 2,546 1 in 2,010 1 in 2,107 1 in 591 1 in 2,326 1 in 1,645 1 in 1,465
C00 Lip 0.6 0.2 0.6 0.4 0.3 0.5 0.4
(0.5–0.7) (0.1–0.3) (0.5–0.7) (0.3–0.5) (0.25–0.35) (0.4–0.6) (0.37–0.43)
1 in 1,240 1 in 4,302 1 in 1,332 1 in 2,296 1 in 2,999 1 in 1,907 1 in 1,991
Female
All All site (H&N) 9.4 6.2 6.8 10.1 8.4 7.3 8.0
(8.9–9.9) (5.7–6.7) (6.5–7.1) (9.7–10.5) (8.2–8.6) (7.1–7.5) (7.9–8.1)
1 in 92 1 in 141 1 in 128 1 in 83 1 in 101 1 in 118 1 in 107
C03-C06 Mouth 4.8 2.6 2.3 3.6 4.0 3.4 3.5
(4.4–5.2) (2.3–2.9) (2.1–2.5) (3.4–3.8) (3.8–4.2) (3.3–3.5) (3.4–3.6)
1 in 174 1 in 340 1 in 384 1 in 234 1 in 204 1 in 254 1 in 244
C01-C02 Tongue 2.7 1.9 2.3 1.6 2.1 2.2 2.1
(2.4–3.0) (1.6–2.2) (2.1–2.5) (1.5–1.7) (2.0–2.2) (2.1–2.3) (2.0–2.2)
1 in 334 1 in 430 1 in 381 1 in 501 1 in 390 1 in 398 1 in 403
C12-C13 Hypopharynx 0.6 0.2 0.5 1.2 0.9 0.6 0.7
(0.5–0.7) (0.1–0.3) (0.4–0.6) (1.1–1.3) (0.8–1.0) (0.5–0.7) (0.66–0.74)
1 in 1,722 1 in 3,364 1 in 2,025 1 in 623 1 in 1,031 1 in 1,478 1 in 1,207
C32 Larynx 0.6 0.6 0.7 1.0 0.4 0.5 0.6
(0.5–0.7) (0.5–0.7) (0.6–0.8) (0.9–1.1) (0.3–0.5) (0.4–0.6) (0.57–0.63)
1 in 1,326 1 in 1,782 1 in 1,157 1 in 820 1 in 2,202 1 in 1,805 1 in 1,455
C11 Nasopharynx 0.1 0.2 0.2 1.1 0.3 0.1 0.3
(0.05–0.15) (0.1–0.3) (0.1–0.3) (1.0–1.2) (0.26–0.34) (0.07–0.13) (0.28–0.32)
1 in 9,394 1 in 4,530 1 in 3,632 1 in 852 1 in3,787 1 in 6,429 1 in 2,791
C09 Tonsil 0.2 0.2 0.3 0.6 0.2 0.1 0.2
(0.1–0.3) (0.1–0.3) (0.2–0.4) (0.5–0.7) (0.17–0.23) (0.07–0.13) (0.18–0.22)
1 in 5,827 1 in 3,142 1 in 3,092 1 in 1,401 1 in 5,387 1 in 5,861 1 in 3,491
C10 Other oropharynx 0.1 0.1 0.2 0.3 0.2 0.1 0.2
(0.05–0.15) (0.04–0.16) (0.1–0.3) (0.2–0.4) (0.16–0.24) (0.07–0.13) (0.18–0.22)
1 in 10,124 1 in 8,048 1 in 3,700 1 in 2,587 1 in 4,333 1 in 6,359 1 in 4,522
C00 Lip 0.3 0.1 0.1 0.3 0.2 0.2 0.2
(0.2–0.4) (0.03–0.17) (0.06–0.14) (0.2–0.4) (0.17–0.23) (0.17–0.23) (0.18–0.22)
1 in 3,091 1 in 6,591 1 in 6,203 1 in 2,512 1 in 5,847 1 in 5,268 1 in 4,612
C14 Pharynx unspecified 0.1 0.1 0.1 0.3 0.2 0.1 0.2
(0.04–0.16) (0.03–0.17) (0.06–0.14) (0.2–0.4) (0.16–0.24) (0.07–0.13) (0.18–0.22)
1 in 9,951 1 in 6,409 1 in 5,637 1 in 3,430 1 in 4,975 1 in 7,284 1 in 5,516

ASIR: Age-standardised incidence rate per 100,000 population, 95% CI (in parenthesis) and cumulative risk (0–74 age group)